Single-chain Tet transregulators

Nucleic Acids Research

Volumn 31, Issue 12, 2003, Pages 3050-3056

  Krueger, Christel ^a   Berens, Christian ^a   Schmidt, Andreas ^a   Schnappinger, Dirk ^a,b   Hillen, Wolfgang ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; MONOMER; REGULATOR PROTEIN; REPRESSOR PROTEIN; HYBRID PROTEIN; TETRACYCLINE RESISTANCE ENCODING TRANSPOSON REPRESSOR PROTEIN; TETRACYCLINE RESISTANCE-ENCODING TRANSPOSON REPRESSOR PROTEIN; TRANSACTIVATOR PROTEIN;

ALLOSTERISM; ARTICLE; CONTROLLED STUDY; ENZYME ASSAY; ESCHERICHIA COLI; EUKARYOTE; GENE ACTIVATION; GENE CONVERSION; GENE EXPRESSION REGULATION; GENE FUSION; GENE SILENCING; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; WESTERN BLOTTING; CELL LINE; CHEMISTRY; DIMERIZATION; DRUG ANTAGONISM; GENETICS; HELA CELL; METABOLISM; PROTEIN TERTIARY STRUCTURE;

ESCHERICHIA COLI; EUKARYOTA;

CELL LINE; DIMERIZATION; ESCHERICHIA COLI; GENE SILENCING; HELA CELLS; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATORS;

EID: 0037901855     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg421     Document Type: Article

References (38)

1. Jana,R., Hazbun,T.R., Fields,J.D. and Mossing,M.C. (1998) Single-chain lambda Cro repressors confirm high intrinsic dimer-DNA affinity. Biochemistry, 37, 6446-6455.
2. Simoncsits,A., Chen,J., Percipalle,P., Wang,S., Toro,I. and Pongor,S. (1997) Single-chain repressors containing engineered DNA-binding domains of the phage 434 repressor recognize symmetric or asymmetric DNA operators. J. Mol. Biol., 267, 118-131.
3. Robinson,C.R. and Sauer,R.T. (1996) Covalent attachment of Arc repressor subunits by a peptide linker enhances affinity for operator DNA. Biochemistry, 35, 109-116.
4. Sieber,M. and Allemann,R.K. (1998) Single chain dimers of MASH-1 bind DNA with enhanced affinity. Nucleic Acids Res., 26, 1408-1413.
5. Muyan,M., Yi,P., Sathya,G., Willmert,L.J., Driscoll,M.D., Hilf,R. and Bambara,R.A. (2001) Fusion estrogen receptor proteins: toward the development of receptor-based agonists and antagonists. Mol. Cell. Endocrinol., 182, 249-263.
6. 2+ reveals mechanism of antibiotic resistance. J. Mol. Biol., 247, 260-280.
7. Orth,P., Schnappinger,D., Hillen,W., Saenger,W. and Hinrichs,W. (2000) Structural basis of gene regulation by the tetracycline inducible Tet repressor-operator system. Nature Struct. Biol., 7, 215-219.
8. Tiebel,B., Garke,K. and Hillen,W. (2000) Observing conformational and activity changes of Tet repressor in vivo. Nature Struct. Biol., 7, 479-481.
9. Bujard,H. and Gossen,M. (2001) Tetracyclines in the control of gene expression in eukaryotes. In Nelson,M., Hillen,W. and Greenwald,R.A. (eds), Tetracyclines in Biology, Chemistry and Medicine. Birkhäuser Verlag, Berlin, pp. 139-157.
10. Gossen,M. and Bujard,H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA, 89, 5547-5551.
11. Gossen,M., Freundlieb,S., Bender,G., Müller,G., Hillen,W. and Bujard,H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
12. Urlinger,S., Baron,U., Thellmann,M., Hasan,M.T., Bujard,H. and Hillen,W. (2000) Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc. Natl Acad. Sci. USA, 97, 7963-7968.
13. Baron,U., Gossen,M. and Bujard,H. (1997) Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res., 25, 2723-2729.
14. Urlinger,S., Helbl,V., Guthmann,J., Pook,E., Grimm,S. and Hillen,W. (2000) The p65 domain from NF-κB is an efficient human activator in the tetracycline-regulatable gene expression system. Gene, 247, 103-110.
15. Akagi,K., Kanai,M., Saya,H., Kozu,T. and Berns,A. (2001) A novel tetracycline-dependent transactivator with E2F4 transcriptional activation domain. Nucleic Acids Res., 29, e23.
16. Deuschle,U., Meyer,W.K. and Thiesen,H.J. (1995) Tetracycline-reversible silencing of eukaryotic promoters. Mol. Cell. Biol., 15, 1907-1914.
17. Rossi,F.M., Guicherit,O.M., Spicher,A., Kringstein,A.M., Fatyol,K., Blakely,B.T. and Blau,H.M. (1998) Tetracycline-regulatable factors with distinct dimerization domains allow reversible growth inhibition by p16. Nature Genet., 20, 389-393.
18. Forster,K., Helbl,V., Lederer,T., Urlinger,S., Wittenburg,N. and Hillen,W. (1999) Tetracycline-inducible expression systems with reduced basal activity in mammalian cells. Nucleic Acids Res., 27, 708-710.
19. Freundlieb,S., Schirra-Muller,C. and Bujard,H. (1999) A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J. Gene Med., 1, 4-12.
20. Baron,U., Schnappinger,D., Helbl,V., Gossen,M., Hillen,W. and Bujard,H. (1999) Generation of conditional mutants in higher eukaryotes by switching between the expression of two genes. Proc. Natl Acad. Sci. USA, 96, 1013-1018.
21. Hillen,W. and Berens,C. (1994) Mechanisms underlying expression of Tn10 encoded tetracycline resistance. Annu. Rev. Microbiol., 48, 345-369.
22. Berens,C., Schnappinger,D. and Hillen,W. (1997) The role of the variable region in Tet repressor for inducibility by tetracycline. J. Biol. Chem., 272, 6936-6942.
23. Wissmann,A., Wray,L.V.,Jr, Somaggio,U., Baumeister,R., Geissendörfer,M. and Hillen,W. (1991) Selection for Tn10 tet repressor binding to ter operator in Escherichia coli: isolation of temperature-sensitive mutants and combinatorial mutagenesis in the DNA binding motif. Genetics, 128, 225-232.
24. Miller,J.H. (1972) Experiments in Molecular Genetics. Cold Spring Harbour Laboratory Press, Cold Spring Harbour, NY.
25. Levy,S.B., McMurry,L.M., Burdett,V., Courvalin,P., Hillen,W., Roberts,M.C. and Taylor,D.E. (1989) Nomenclature for tetracycline resistance determinants. Antimicrob. Agents Chemother., 33, 1373-1374.
26. Gossen,M., Freundlieb,S., Bender,G., Muller,G., Hillen,W. and Bujard,H. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science, 268, 1766-1769.
27. Berens,C., Altschmied,L. and Hillen,W. (1992) The role of the N terminus in Tet repressor for ter operator binding determined by a mutational analysis. J. Biol. Chem., 267, 1945-1952.
28. Goldman,E., Rosenberg,A.H., Zubay,G. and Studier,F.W. (1995) Consecutive low-usage leucine codons block translation only when near the 5′ end of a message in Escherichia coli. J. Mol. Biol., 245, 467-473.
29. Knott,A., Garke,K., Urlinger,S., Guthmann,J., Müller,Y., Thellmann,M. and Hillen,W. (2002) Tetracycline-dependent gene regulation: combinations of transregulators yield a variety of expression windows. Biotechniques, 32, 796-807.
30. Robinson,C.R. and Sauer,R.T. (1998) Optimizing the stability of single-chain proteins by linker length and composition mutagenesis. Proc. Natl Acad. Sci. USA, 95, 5929-5934.
31. Huston,J.S., Levinson,D., Mudgett-Hunter,M., Tai,M.S., Novotny,J., Margolies,M.N., Ridge,R.J., Bruccoleri,R.E., Haber,E., Crea,R. et al. (1988) Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc. Natl Acad. Sci. USA, 85, 5879-5883.
32. Rossi,F.M., Kringstein,A.M., Spicher,A., Guicherit,O.M. and Blau,H.M. (2000) Transcriptional control: rheostat converted to on/off switch. Mol. Cell, 6, 723-728.
33. Mizuguchi,H, and Hayakawa,T. (2001) Characteristics of adenovirus-mediated tetracycline-controllable expression system. Biochim. Biophys Acta, 1568, 21-29.
34. Zhu,Z., Ma,B., Homer,R.J., Zheng,T. and Elias,J.A. (2001) Use of the tetracycline controlled transcriptional silencer (tTS) to eliminate transgene leak in inducible overexpression transgenic mice. J. Biol. Chem., 30, 30.
35. Lamartina,S., Roscilli,G., Rinaudo,C.D., Sporeno,E., Silvi,L., Hillen,W., Bujard,H., Cortese,R., Ciliberto,G. and Toniatti,C. (2002) Stringent control of gene expression in vivo by using novel doxycycline-dependent trans-activators. Hum Gene Ther., 13, 199-210.
36. Gill,G. and Ptashne,M. (1988) Negative effect of the transcriptional activator GAL4. Nature, 334, 721-724.
37. Gilbert,D.M., Heery,D.M., Losson,R., Chambon,P. and Lemoine,Y. (1993) Estradiol-inducible squelching and cell growth arrest by a chimeric VP16-estrogen receptor expressed in Saccharomyces cerevisiae: suppression by an allele of PDR1. Mol. Cell. Biol., 13, 462-472.
38. Yueh,Y.G., Yaworsky,P.J. and Kappen,C. (2000) Herpes simplex virus transcriptional activator VP16 is detrimental to preimplantation development in mice. Mol. Reprod. Dev., 55, 37-46.